News

A downtrend has been apparent in Inhibikase Therapeutics, Inc. (IKT) lately. While the stock has lost 15.4% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was ...
The Ikt Wireless Earbuds are on sale for just $15, which is a massive 88% discount from their original $130 price. Walmart shoppers praise these earbuds for everything from their sound quality to ...
Shares of Inhibikase Therapeutics, Inc. (IKT) have been struggling lately and have lost 6.6% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...
If you buy something via one of our links, we may earn a commission. The IKT A10 Bluetooth Wireless Earbuds are on sale for just $15 right now at Walmart, a phenomenal 88% discount on their normal ...
Inhibikase Therapeutics shares are trading higher by 50% during Wednesday's session. The company announced the pricing of an approximately $110 million private placement financing. Get stock ...
It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as ...
Inhibikase Therapeutics pivots to focus on IkT-001Pro for pulmonary arterial hypertension after risvodetinib's failure in Parkinson's disease, leveraging imatinib's prior data. The company is well ...